Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook

FREMONT, Calif., Feb. 28, 2024 -- Cytek® Biosciences, Inc. , a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2023....

Related Keywords

Fremont ,California ,United States ,China ,Wenbin Jiang ,Cytek Aurora ,Cytek Orion ,Stephanie Olsen ,Cytek Biosciences ,Cytek Bioscience ,Pauld Goodson ,Lages Associates ,Linkedin ,European Union ,Luminex Corporation On ,Biosciences Inc ,Twitter ,Securities Exchange ,Exchange Commission ,Cytek Biosciences Inc ,Centre For Genomic Regulation ,Pompeu Fabra University ,Luminex Corporation ,Genomic Regulation ,Full Spectrum Profiling ,Northern Lights ,Regarding Use ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Quarterly Report ,Annual Report ,Relations Contact ,Comprehensive Income ,Markets ,